These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34392921)

  • 21. PET and PET-CT imaging of gynecological malignancies: present role and future promise.
    Basu S; Li G; Alavi A
    Expert Rev Anticancer Ther; 2009 Jan; 9(1):75-96. PubMed ID: 19105709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls.
    De Gaetano AM; Calcagni ML; Rufini V; Valentini AL; Gui B; Giordano A; Bonomo L
    Abdom Imaging; 2009 Nov; 34(6):696-711. PubMed ID: 18791682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDG PET-CT of gynecologic cancers: pearls and pitfalls.
    Prabhakar HB; Kraeft JJ; Schorge JO; Scott JA; Lee SI
    Abdom Imaging; 2015 Oct; 40(7):2472-85. PubMed ID: 25680500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it.
    Nogami Y; Banno K; Irie H; Iida M; Kisu I; Masugi Y; Tanaka K; Tominaga E; Okuda S; Murakami K; Aoki D
    Jpn J Clin Oncol; 2015 Jan; 45(1):26-34. PubMed ID: 25368102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET/MRI and PET/CT in advanced gynaecological tumours: initial experience and comparison.
    Queiroz MA; Kubik-Huch RA; Hauser N; Freiwald-Chilla B; von Schulthess G; Froehlich JM; Veit-Haibach P
    Eur Radiol; 2015 Aug; 25(8):2222-30. PubMed ID: 26017734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on advances in molecular PET in urological oncology.
    Kitajima K; Yamamoto S; Fukushima K; Minamimoto R; Kamai T; Jadvar H
    Jpn J Radiol; 2016 Jul; 34(7):470-85. PubMed ID: 27222021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positron Emission Tomography/Computed Tomography for Gynecologic Malignancies.
    Oldan JD; Patel PS
    Obstet Gynecol Surv; 2016 Sep; 71(9):545-56. PubMed ID: 27640609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal Variants and Pitfalls Encountered in PET Assessment of Gynecologic Malignancies.
    Yu JQ; Doss M; Alpaugh RK
    PET Clin; 2018 Apr; 13(2):249-268. PubMed ID: 29482753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomography in gynecologic cancer.
    Yen TC; Lai CH
    Semin Nucl Med; 2006 Jan; 36(1):93-104. PubMed ID: 16356798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron emission tomography scanning in gynecologic and breast cancers.
    Zimny M; Siggelkow W
    Curr Opin Obstet Gynecol; 2003 Feb; 15(1):69-75. PubMed ID: 12544505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
    Torizuka T; Kanno T; Futatsubashi M; Okada H; Yoshikawa E; Nakamura F; Takekuma M; Maeda M; Ouchi Y
    J Nucl Med; 2003 Jul; 44(7):1051-6. PubMed ID: 12843219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular imaging in the management of gynecologic malignancies.
    Lai CH; Lin G; Yen TC; Liu FY
    Gynecol Oncol; 2014 Oct; 135(1):156-62. PubMed ID: 25065896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applications of PET/MR Imaging in Urogynecologic and Genitourinary Cancers.
    Oldan JD; Shah SN; Rose TL
    Magn Reson Imaging Clin N Am; 2017 May; 25(2):335-350. PubMed ID: 28390533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDG PET/CT Pitfalls in Gynecologic and Genitourinary Oncologic Imaging.
    Lakhani A; Khan SR; Bharwani N; Stewart V; Rockall AG; Khan S; Barwick TD
    Radiographics; 2017; 37(2):577-594. PubMed ID: 28287942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gynecologic tumor board: a radiologist's guide to vulvar and vaginal malignancies.
    Chow L; Tsui BQ; Bahrami S; Masamed R; Memarzadeh S; Raman SS; Patel MK
    Abdom Radiol (NY); 2021 Dec; 46(12):5669-5686. PubMed ID: 34435227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of FDG-PET/CT in gynecologic imaging: an updated guide to interpretation and challenges.
    Akin EA; Kuhl ES; Zeman RK
    Abdom Radiol (NY); 2018 Sep; 43(9):2474-2486. PubMed ID: 29520427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer.
    Khan N; Oriuchi N; Yoshizaki A; Kanuma T; Higuchi T; Endo K
    Ann Nucl Med; 2005 Apr; 19(2):137-45. PubMed ID: 15909494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gynecologic imaging: current and emerging applications.
    Iyer VR; Lee SI
    J Postgrad Med; 2010; 56(2):117-24. PubMed ID: 20622391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fludeoxyglucose F 18 PET-Computed Tomography: Management Changes Effecting Patient Outcomes in Gynecologic Malignancies.
    Brunetti JC
    PET Clin; 2015 Jul; 10(3):395-409. PubMed ID: 26099674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.